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TO THE EDITOR
The conserved p53-binding protein 1
(53BP1) was initially identified as a
nuclear protein that interacts with the
DNA-binding domain of tumor suppres-
sor p53 and enhances p53-mediated
transcription activation (Iwabuchi et al.,
1998). The interaction region of 53BP1,
BRCT (BRCA1 C-terminus) repeats, are
present in several proteins involved in
DNA repair and cell cycle control,
suggesting a direct role of 53BP1 in
the cellular response to DNA damage
and maintenance of genomic stability
(Rappold et al., 2001; Joo et al., 2002).
Recently, studies suggested that 53BP1
is a central mediator of the DNA
damage checkpoint signaling (Wang
et al., 2002) and it directly participates
in the repair for DNA double-strand
breaks (Huyen et al., 2004). 53BP1-
deficient mice exhibit growth retarda-
tion, high-radiation sensitivity, and
tumor development features that are
indicative of a defective DNA damage
response (Ward et al., 2003). 53BP1 has
been shown to constitutively have an
important role in the etiology of human
cancer (DiTullio et al., 2002). It is
plausible that sequence variation in
the regulatory and coding regions of
the 53BP1 gene might affect its tran-
scription and protein structure thus,
its biological function in checkpoint
signaling and DNA repair, leads to
susceptibility to cancers.
In this study, we hypothesized that
that common genetic variants of 53BP1
were associated with risk of skin
cancer. We comprehensively surveyed
common genetic variation of the 53BP1
gene using two complementary ap-
proaches, including putatively func-
tional single nucleotide polymorphisms
(SNPs) and choosing tagging-SNPs in
the 53BP1 gene locus (introns and
exons as well as 20 kb upstream and
20 kb downstream of the coding re-
gion). We performed a skin cancer
case-control study of Caucasians nested
within the Nurses’ Health Study to
evaluate whether these common genet-
ic variants are associated with the risks
of non-melanoma skin cancers (squa-
mous cell carcinoma (SCC) and basal
cell carcinoma (BCC)) along with mel-
anoma risk. We further investigated the
association of these genetic variants
with pigmentary phenotypes (hair
color, skin color, tanning ability, and
the number of moles). The nested case-
control study consisted of 218 incident
melanoma cases, 285 incident SCC
cases, 300 incident BCC cases, and
870 age-matched controls. A detailed
description of the selection and char-
acteristics of cases and controls was
published previously (Han et al., 2005).
We included four putatively func-
tional SNPs that have been identified in
the promoter and coding regions of
53BP1 (http://egp.gs.washington.edu):
rs1869258, rs560191, rs689647, and
rs2602141. Using genotype data from
the 90 CEU samples in the HapMap
project, we further selected four tag-
ging-SNPs by the Tagger program
(r240.8): rs3862138, rs17782975,
rs2242069, and rs999047 (Supplemen-
tary Figure S1 online and Supplemen-
tary Table S1 online). We genotyped
the eight SNPs by the 50 nuclease assay
(TaqMan) in 384-well format, using the
ABI PRISM 7900HT Sequence Detec-
tion System (Applied Biosystems,
Foster City, CA). The distributions of
genotypes for the eight SNPs were in
Hardy–Weinberg equilibrium among
controls. Because the three SNPs
(rs1869258, rs560191, and rs2602141)
are in high linkage disequilibrium
(each pair-wise r240.9, Supplementary
Table S2 online), we anticipated that
these three SNPs would show similar
effects on pigmentary phenotypes and
skin cancer risk.
We evaluated the main effect of
the selected polymorphisms across the
three types of skin cancer using un-
conditional logistic regression (Table 1).
In the analyses controlling for the age,
we found that three SNPs (rs689647,
rs2242069, and rs999047) were con-
sistently associated with a significantly
decreased risk of BCC (additive odds
ratio and 95% confidence interval: 0.69
(0.50–0.95), 0.68 (0.51–0.90), and 0.66
(0.48–0.91), respectively). These three
SNPs are in moderate linkage disequili-
brium (pair-wise r2 between 0.27 and
0.70, Supplementary Table S2 online).
Abbreviations: BCC, basal cell carcinoma; SCC, squamous cell carcinoma; SNP, single nucleotide
polymorphism
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Table 1. Associations between selected SNPs in 53BP1 region and skin cancer risk
Melanoma SCC BCC
Controls (%) Cases (%) Multivariate OR1 Cases (%) Multivariate OR1 Cases (%) Multivariate OR1
50 UTR
rs3862138
CC 503 (62.9) 132 (63.5) 1.00 (ref) 173 (66.3) 1.00 (ref) 179 (65.1) 1.00 (ref)
CT+TT 297 (37.1) 76 (36.5) 0.99 (0.721.36) 88 (33.7) 0.85 (0.63–1.14) 96 (34.9) 0.90 (0.681.21)
Per copy of T 0.93 (0.711.24) 0.95 (0.74–1.21) 0.98 (0.771.24)
P for trend 0.64 0.66 0.86
Coding region
rs17782975
TT 670 (81.8) 168 (82.4) 1.00 (ref) 222 (81.0) 1.00 (ref) 227 (82.8) 1.00 (ref)
TC+CC 149 (18.2) 36 (17.6) 0.96 (0.641.44) 52 (19.0) 1.05 (0.74–1.49) 47 (17.2) 0.92 (0.641.33)
Per copy of C 1.00 (0.681.48) 1.10 (0.79–1.52) 0.92 (0.651.30)
P for trend 0.99 0.58 0.62
rs689647 (G412S)
CC 635 (76.5) 155 (75.2) 1.00 (ref) 225 (82.1) 1.00 (ref) 243 (82.9) 1.00 (ref)
CT+TT 195 (23.5) 51 (24.8) 1.08 (0.761.55) 49 (17.9) 0.71 (0.50–1.01) 50 (17.1) 0.68 (0.480.95)
Per copy of T 1.05 (0.76–1.46) 0.74 (0.53–1.02) 0.69 (0.500.95)
P for trend 0.77 0.07 0.02
rs2602141 (K1136Q)2
TT 389 (46.4) 86 (41.0) 1.00 (ref) 143 (52.4) 1.00 (ref) 154 (52.0) 1.00 (ref)
TG+GG 449 (53.6) 124 (59.0) 1.27 (0.93–1.72) 130 (47.6) 0.78 (0.60–1.03) 142 (48.0) 0.80 (0.611.05)
Per copy of G 1.05 (0.83–1.34) 0.85 (0.69–1.06) 0.86 (0.701.06)
P for trend 0.67 0.14 0.15
rs2242069
TT 545 (67.0) 132 (65.3) 1.00 (ref) 194 (72.9) 1.00 (ref) 212 (76.3) 1.00 (ref)
TG+GG 269 (33.0) 70 (34.7) 1.09 (0.79–1.52) 72 (27.1) 0.75 (0.55–1.02) 66 (23.7) 0.63 (0.460.86)
Per copy of G 1.13 (0.85–1.50) 0.83 (0.63–1.09) 0.68 (0.510.90)
P for trend 0.41 0.18 0.01
30 UTR
rs999047
AA 597 (74.5) 136 (69.7) 1.00 (ref) 220 (80.3) 1.00 (ref) 226 (81.9) 1.00 (ref)
AG+GG 204 (25.5) 59 (30.3) 1.29 (0.91–1.82) 54 (19.7) 0.72 (0.51–1.00) 50 (18.1) 0.65 (0.460.91)
Per copy of G 1.23 (0.90–1.68) 0.82 (0.60–1.10) 0.66 (0.480.91)
P for trend 0.2 0.18 0.01
Haplotype (A B C D)3
0 0 0 0 863 (61.1) 203 (59.3) 1.00 288 (61.5) 1.00 326 (65.3) 1.00
0 1 0 0 279 (19.8) 63 (18.5) 0.97 (0.70–1.35) 92 (19.7) 0.99 (0.75–1.30) 98 (19.5) 0.92 (0.711.21)
1 1 1 1 160 (11.3) 40 (11.7) 1.08 (0.73–1.60) 42 (9.0) 0.78 (0.54–1.13) 40 (8.0) 0.66 (0.450.96)
0 0 1 0 73 (5.2) 21 (6.2) 1.28 (0.76–2.17) 27 (5.7) 1.12 (0.69–1.82) 26 (5.2) 0.89 (0.551.43)
0 0 0 1 24 (1.7) 11 (3.2) 1.97 (0.96–4.07) 11 (2.4) 1.40 (0.68–2.87) 5 (1.1) 0.59 (0.221.61)
Rareo1% combined 12 (0.9) 4 (1.2) 1.42 (0.45–4.54) 8 (1.8) 1.92 (0.80–4.63) 4 (0.9) 0.89 (0.292.75)
P for global test 0.52 0.40 0.31
Abbreviations: BCC, basal cell carcinoma; OR, odds ratio; SCC, squamous cell carcinoma; SNP, single nucleotide polymorphism; UTR, untranslated region;
53BP1, p53-binding protein 1.
1Unconditional logistic regression adjusted for age;
2The two SNPs (rs1869258 and rs560191) that are in high linkage disequilibrium with rs2602141 (each pair-wise r240.9) showed similar associations with
the risk of melanoma, SCC and BCC.
3Haplotype based on the four SNPs A: rs689647; B: rs2602141; C:rs2242069; D: rs999047; 0, wild-type allele; 1, variant allele.
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The non-synonymous SNP, rs689647
(G412S), has been investigated in a
case-control study of breast cancer but
found no association with breast cancer
risk (Frank et al., 2005). We did not
observe significant association between
three putatively functional SNPs
(rs1869258, rs560191, and rs2602141)
and any type of skin cancer, which was
consistent with previous studies (Frank
et al., 2005; Ma et al., 2006; Rapakko
et al., 2007). We further evaluated
haplotypes based on the four SNPs
(rs689647, rs2602141, rs2242069, and
rs999047) that modified the risk of the
cancer subtypes (Table 1). We found
that the variant allele of rs689647 was
often inherited together with that of the
other three SNPs and formed a haplo-
type in 11% of the population. This
haplotype was significantly associated
with a decreased risk of BCC (odds
ratio, 0.66; 95% confidence interval,
0.45–0.96), suggesting a protective ef-
fect on BCC compared with the most
frequent haplotype carrying all wild-
type alleles in approximately 60% of
the population. However, the haplo-
type carrying only the variant allele of
rs2242066 or rs999047 was not sig-
nificantly associated with BCC risk
as suggested in single-SNP analysis,
though the latter showed a non-signifi-
cant decreased risk of BCC. Of note, the
last haplotype carrying only the variant
allele of rs999047 was associated with
a non-significant increased risk of
melanoma (odds ratio, 1.97; 95% con-
fidence interval, 0.96–4.07), which was
stronger than the association of single-
SNP analysis (odds ratio, 1.23; 95%
confidence interval, 0.90–1.68). These
associations did not change substan-
tially after additional adjustment for
potential risk factors including pigmen-
tary phenotypes, family history of skin
cancer, geographic region, accumula-
tive sun exposure, sunburns, and sun-
lamp use or tanning salon attendance.
We did not observe any statistically
significant interaction between pigmen-
tary phenotypes and genetic variants on
skin cancer risk.
We evaluated the associations be-
tween the selected SNPs and pigmentary
phenotypes among controls using linear
regression models (Table 2). We found
the three highly correlated putatively
functional SNPs (rs1869258, rs560191,
and rs2602141) were associated with
lighter hair color (P for trend, 0.04, 0.07,
and 0.03, respectively) and more moles
(P for trend, 0.02, 0.003, and 0.003,
respectively). We also found one intro-
nic SNP in 50 terminus, rs17782975, was
significantly associated with more moles
(P for trend, 0.01). No statistically
significant associations between genetic
variants and skin color or tanning ability
were observed. To our knowledge, this
is the first report that 53BP1 is associated
with pigmentary phenotypes in Cauca-
sians, although this gene has shown
clear evidence of adaptive skin pigmen-
tation selection in Africans (Izagirre
et al., 2006). Two other genes involved
in DNA repair, p53 and MDM2, have
been reported to be associated with
pigmentary phenotypes (Cui et al.,
2007; Nan et al., 2009).
In summary, we systematically eval-
uated the common genetic variants
of the 53BP1 gene and the risk of
skin cancer. We found three SNPs
(rs689647, rs2242069, and rs999047)
were significantly associated with a
decreased risk of BCC. These findings
may lead to further replication and
functional studies that will elucidate
the underlying mechanisms of skin
cancer development associated with
these genetic variants.
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TO THE EDITOR
Recessive dystrophic epidermolysis
bullosa (RDEB) is a devastating inher-
ited skin disease caused by mutations in
the gene encoding type VII collagen
(Christiano et al., 1993). The condition is
characterized by skin fragility, trauma-
induced skin blistering, and chronic
non-healing wounds (Mellerio et al.,
2007). Patients with RDEB are at
strongly increased risk of developing
aggressive cutaneous squamous cell
carcinoma (SCC), which is the cause
of death by age 45 years in 70% of
individuals with the most severe form of
RDEB (Fine et al., 2009). Potential
similarities between the microenviron-
ment of non-healing wounds and
mucosal epithelia, wherein human
papillomaviruses (HPVs) have been
shown to induce the development of
SCC (Zur Hausen, 2009), led us to
investigate whether HPV infection
could be responsible for the increased
incidence and aggressive nature of
RDEB SCC. The involvement of HPV
in the development of cutaneous SCC
remains controversial, except in the
rare genodermatosis epidermodysplasia
verruciformis, wherein up to 60% of
patients develop SCC containing high
copy numbers of beta-papillomavirus
(b-PV) (Harwood and Proby, 2002), which
may be restricted to a minority of tumor
cells (Dell’Oste et al., 2009). The possi-
bility that HPV are also involved in
RDEB SCC has not been addressed.
HPVs are a diverse group of small
double-stranded DNA viruses that in-
fect squamous epithelial cells. The two
largest genera are alpha-papillomavirus
(a-PV), comprising all HPV genotypes
found in mucosal lesions as well as many
of those associated with benign skin
warts, and b-PV, containing HPV types,
which have most frequently been asso-
ciated with epidermodysplasia verruci-
formis and cutaneous SCC (de Villiers
et al., 2004). Because vaccines against
prevalent high risk mucosal/genital HPV
(HPV16/18) are available and effective
at preventing cancer development
(Zur Hausen, 2009), we tested RDEB
SCC for the presence of 18 high risk
a-PV types using the digene HPV
genotyping reverse hybridization assay
detection kit (Qiagen, Leiden, The
Netherlands). We tested DNA prepared
from 21 separate SCC isolated from
12 RDEB patients as well as DNA
from 39 organ transplant recipient
SCC and 18 immunocompetent SCC
collected for a separate study (Purdie
et al., 2009) with 6 vulval SCC samples
included as positive controls. All DNA
were isolated from frozen tissue col-
lected after informed consent and in
accordance with Helsinki guidelines
following research ethics committee
approval. All cutaneous SCC from
RDEB and non-RDEB individuals were
negative, whereas nine different a-PV
types were detected in the vulval SCC
samples.
Next we tested the presence of b-PV
using the reverse hybridization assay kit
skin (b) HPV detection system (Diassay,
Rijswijk, The Netherlands) (de Koning
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